Secondary Logo

Journal Logo

Articles by Michel Dupon

Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients

Thiébaut, Rodolphe; Hue, Sophie; Le Marec, Fabien; More

AIDS. 31(17):2355-2365, November 13, 2017.

Reduced bone mineral density in HIV-infected patients: prevalence and associated factors

Cazanave, Charles; Dupon, Michel; Lavignolle-Aurillac, Valérie; More

AIDS. 22(3):395-402, January 30th, 2008.

Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999–2004

Thiébaut, Rodolphe; Aurillac-Lavignolle, Valérie; Bonnet, Fabrice; More

AIDS. 19(7):729-731, April 29th, 2005.

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

Rancinan, Corinne; Neau, Didier; Savès, Marianne; More

AIDS. 16(10):1357-1362, July 5th, 2002.

Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998

Savès, Marianne; Vandentorren, Stéphanie; Daucourt, Valentin; More

AIDS. 13(17):115-151, December 3rd, 1999.

Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985–1993

Dupon, Michel; Texier-Maugein, Jeannette; Leroy, Valériane; More

AIDS. 9(6):577-584, June 1995.